NCT06642831View on ClinicalTrials.gov

Polycystic Ovarian Syndrome (PCOS) Biomarker Evaluation Study

RecruitingOBSERVATIONAL

Enrollment

380

Participants

Timeline

Start Date

January 31, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

March 31, 2027

Conditions

Polycystic Ovarian Syndrome (PCOS)

Trial Locations (1)

91054

RECRUITING

Department of Obstetrics and Gynecology, University Erlangen Hospital, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany, Erlangen

All Listed Sponsors

collaborator

Roche Diagnostics International AG

INDUSTRY

lead

University Hospital Erlangen

OTHER